AlphaQuest’s OptimizeRx OPRX Stock Holding History

AlphaQuest’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-9,800	Closed	-$75.7K	–	1927
2024 Q3	$75.7K	Buy	9,800 +9,739	+15,966%	+$86.6K	0.01%	1347
2024 Q2	$610	Buy	+61	New	+$670	﹤0.01%	1388

Other funds holding OPRX

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AlphaQuest's OPRX Position: Q4 2024 in Review

AlphaQuest sold out of OptimizeRx (OPRX) in Q4 2024, closing a stake of 9,800 shares — an estimated $75.7K sold.

AlphaQuest first reported a position in OPRX in Q2 2024 and held it in 2 quarters. The position peaked at $75.7K in Q3 2024. 87 funds tracked by Wall St. Rank hold OPRX as of Q4 2024.

AlphaQuest reported no remaining OptimizeRx position as of Q4 2024 after selling out during the quarter.
AlphaQuest sold 9,800 OptimizeRx shares in Q4 2024, an estimated $75.7K.
AlphaQuest first reported a position in OptimizeRx in Q2 2024 and held it in 2 quarters.
AlphaQuest's OptimizeRx position peaked at $75.7K in Q3 2024.
87 funds tracked by Wall St. Rank held OptimizeRx as of Q4 2024.

Based on AlphaQuest's 13F filing for Q4 2024, filed 7 Feb 2025.